Oxford Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.36M | Buy |
+24,736
| New | +$1.36M | 0.49% | 30 |
|
|
2019
Q3 | – | Sell |
-61,908
| Closed | -$5.3M | – | 1714 |
|
|
2019
Q2 | $5.3M | Buy |
+61,908
| New | +$5.3M | 0.11% | 213 |
|
|
2018
Q4 | – | Sell |
-11,492
| Closed | -$1.12M | – | 1788 |
|
|
2018
Q3 | $1.12M | Buy |
11,492
+188
| +2% | +$18.4K | 0.02% | 952 |
|
|
2018
Q2 | $1.06M | Buy |
+11,304
| New | +$1.06M | 0.02% | 1009 |
|
|
2018
Q1 | – | Sell |
-9,629
| Closed | -$859K | – | 1618 |
|
|
2017
Q4 | $859K | Buy |
9,629
+4,780
| +99% | +$426K | 0.02% | 996 |
|
|
2017
Q3 | $452K | Buy |
+4,849
| New | +$452K | 0.01% | 1230 |
|
|
2015
Q2 | – | Sell |
-10,672
| Closed | -$1.33M | – | 668 |
|
|
2015
Q1 | $1.33M | Sell |
10,672
-23,282
| -69% | -$2.9M | 0.03% | 418 |
|
|
2014
Q4 | $3.13M | Buy |
+33,954
| New | +$3.13M | 0.07% | 279 |
|